These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 239225)

  • 1. Modification by lithium of transmitter release at the neuromuscular junction of the frog.
    Branisteanu DD; Volle RL
    J Pharmacol Exp Ther; 1975 Aug; 194(2):362-72. PubMed ID: 239225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 4-aminopyridine and 3,4-diaminopyridine on transmitter release at the neuromuscular junction.
    Thomsen RH; Wilson DF
    J Pharmacol Exp Ther; 1983 Oct; 227(1):260-5. PubMed ID: 6137556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lithium ions and the release of transmitter at the frog neuromuscular junction.
    Crawford AC
    J Physiol; 1975 Mar; 246(1):109-42. PubMed ID: 237119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 4-aminopyridine at the frog neuromuscular junction.
    Molgo J; Lemeignan M; Lechat P
    J Pharmacol Exp Ther; 1977 Dec; 203(3):653-63. PubMed ID: 21957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depression of synaptic transmission by diphenylhydantoin.
    Yaari Y; Pincus JH; Argov Z
    Ann Neurol; 1977 Apr; 1(4):334-8. PubMed ID: 31132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of calcium ions on bimodal parameters of mediator liberation in frog sartorius muscle neuromuscular junctions].
    Zefirov AL
    Fiziol Zh SSSR Im I M Sechenova; 1980 Apr; 66(4):531-6. PubMed ID: 6104608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statistical parameters of transmitter release at frog neuromuscular junctions treated with guanidine or tetraethylammonium.
    Volle RL; Branisteanu DD
    J Pharmacol Exp Ther; 1976 Jun; 197(3):653-61. PubMed ID: 6788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transmitter mobilization at the frog neuromuscular junction.
    Alkadhi K; Volle RL
    Arch Int Pharmacodyn Ther; 1977 Oct; 229(2):261-75. PubMed ID: 23083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual action of ouabain on transmitter release at neuromuscular junctions of the frog.
    Brănişteanu DD; Proca B; Haulică ID
    J Pharmacol Exp Ther; 1979 Apr; 209(1):31-6. PubMed ID: 34716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in transmitter release from motor nerve terminals induced by some pyridine derivatives.
    Montoya GA; Molgó J; Lemeignan M; Lechat P
    Acta Physiol Pharmacol Latinoam; 1984; 34(4):409-18. PubMed ID: 6242265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial lipopolysaccharide depresses spontaneous, evoked, and ionophore-induced transmitter release at the neuromuscular junction.
    Person RJ
    J Neurosci Res; 1979; 4(2):105-14. PubMed ID: 229236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of imidazole on neuromuscular transmission and on synaptosomal calcium uptake in the rat.
    Ribeiro JA; Dominguez ML; Sá-Aimeida AM; Gonçalves MJ
    Arch Int Pharmacodyn Ther; 1981 Jun; 251(2):270-84. PubMed ID: 6269509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of primidone, phenobarbital and phenylethylmalonamide in the stimulated frog neuromuscular junction.
    Talbot PA; Alderdice MT
    J Pharmacol Exp Ther; 1984 Jan; 228(1):121-7. PubMed ID: 6607337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Binomial parameters of mediator release in the process of facilitation of neuromuscular transmission].
    Zefirov AL
    Neirofiziologiia; 1980; 12(3):314-6. PubMed ID: 6105625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of N-ethylmaleimide on transmitter release from the skeletal neuromuscular junction of Bufo marinus.
    Knight D; Bellingham MC; Lavidis NA
    Synapse; 2004 Sep; 53(3):151-8. PubMed ID: 15236347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of the anticonvulsants phenobarbital, ethosuximide and carbamazepine on neuromuscular transmission.
    Alderdice MT; Trommer BA
    J Pharmacol Exp Ther; 1980 Oct; 215(1):92-6. PubMed ID: 6256522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes of quantal transmitter release caused by gadolinium ions at the frog neuromuscular junction.
    Molgó J; del Pozo E; Baños JE; Angaut-Petit D
    Br J Pharmacol; 1991 Sep; 104(1):133-8. PubMed ID: 1686201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Variations in the sensitivity of the neuromuscular junctions of the frog to the blocking action of hyperkalemic solutions].
    Dobretsov MG
    Fiziol Zh SSSR Im I M Sechenova; 1987 Mar; 73(3):366-72. PubMed ID: 3034684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primidone but not phenylethylmalonamide, a major metabolite, increases nerve-evoked transmitter release at the frog neuromuscular junction.
    Talbot PA; Alderdice MT
    J Pharmacol Exp Ther; 1982 Jul; 222(1):87-93. PubMed ID: 6123595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Participation of calcium ions in stannous chloride-induced facilitation of transmitter release from frog motor nerve terminals.
    Hattori T; Maehashi H
    Res Commun Chem Pathol Pharmacol; 1990 May; 68(2):267-70. PubMed ID: 1972290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.